![]() ![]() Inadequate direct evidence on the harms of screening for cognitive impairment Harms of early detection and intervention and treatment Inadequate evidence on the benefits of interventions targeting decision-making or planning by patients, caregivers, or clinicians Inadequate evidence on the benefits of other medications or supplements (e.g., statins, antihypertensives, vitamins) and nonpharmacologic interventions targeted to patientsĪdequate evidence that interventions to support caregivers have a small effect on measures of caregiver burden and depression, but the clinical importance of these effects is uncertain, and the generalizability of these findings to persons with previously unrecognized dementia, detected by screening, is not known Inadequate direct evidence on the benefits of screening for cognitive impairmentĪdequate evidence that AChEIs and memantine have a small effect on measures of cognitive function in the short term for patients with mild to moderate dementia, but it is uncertain whether the effects reported in studies are clinically meaningful or sustained over the long term Sensitivity and specificity of screening tools are generally lower for the detection of MCI than they are for dementiaīenefits of early detection and intervention and treatment However, because of lower prevalence, the positive predictive value can be closer to 20% in unselected populations of adults aged 65 to 74 years ![]() When the prevalence of dementia is high (e.g., in persons ≥ 85 years), positive predictive values can be greater than 50%. This includes more details on the rationale of the recommendation, including benefits and harms supporting evidence and recommendations of others.Īdequate evidence that some screening tools have relatively high sensitivity and specificity for the detection of dementia Visit the USPSTF website ( ) to read the full recommendation statement. Where to read the full recommendation statement? Clinicians should remain alert to early signs or symptoms of cognitive impairment (e.g., problems with memory or language) and evaluate as appropriate. There is insufficient evidence to recommend for or against screening for cognitive impairment. This recommendation is consistent with the 2014 USPSTF statement. It does not apply to persons who are hospitalized or living in institutions such as nursing homes. ![]() More research is needed.Ĭommunity-dwelling adults ≥ 65 years without recognized signs or symptoms of cognitive impairment The USPSTF found that the evidence is insufficient to assess the balance of benefits and harms of screening for cognitive impairment in older adults. For asymptomatic, community-dwelling adults ≥ 65 years: I statement ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |